Stay updated with breaking news from Keytruda Combination. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Moderna and MSD have announced follow-up data from the Phase IIb clinical trial evaluating cancer vaccine mRNA-4157 in combination with MSD's Keytruda in patients with resected high-risk...
-Record Net Product Sales of $544 Million in 2Q23, an Increase of 26% Over 2Q22, Contributing to Total Revenues of $604 Million in 2Q23- -Strong PADCEV® Growth Driven By Combination First-Line...